Cargando…

Incidence and predictors of COVID-19 and flares in patients with rare autoimmune diseases: a systematic survey and serological study at a national reference center in France

BACKGROUND: The risk of severe COVID-19 and its determinants remain largely unknown in patients with autoimmune and inflammatory rheumatic diseases. The objective of this study was to assess the prevalence of COVID-19 infection in patients followed for rare autoimmune diseases as well as the predict...

Descripción completa

Detalles Bibliográficos
Autores principales:	Felten, Renaud, Scherlinger, Marc, Guffroy, Aurélien, Poindron, Vincent, Meyer, Alain, Giannini, Margherita, Korganow, Anne-Sophie, Sordet, Christelle, Chatelus, Emmanuel, Javier, Rose-Marie, Meyer, Aurore, Pijnenburg, Luc, Kleinmann, Jean-François, Gottenberg, Jacques-Eric, Sibilia, Jean, Martin, Thierry, Arnaud, Laurent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276223/ https://www.ncbi.nlm.nih.gov/pubmed/34256812 http://dx.doi.org/10.1186/s13075-021-02565-0

Ejemplares similares

Effect of SARS-CoV-2 Vaccination on Symptoms from Post-Acute Sequelae of COVID-19: Results from the Nationwide VAXILONG Study
por: Scherlinger, Marc, et al.
Publicado: (2021)

Effet de la vaccination anti-SARS-CoV-2 sur les symptômes prolongés post-Covid : résultat de l’enquête nationale VAXILONG
por: Scherlinger, M., et al.
Publicado: (2021)

Cellular and humoral immunity after the third dose of SARS-CoV-2 vaccine in patients treated with rituximab
por: Felten, Renaud, et al.
Publicado: (2022)

10 most important contemporary challenges in the management of SLE
por: Felten, Renaud, et al.
Publicado: (2019)

Vaccination against COVID-19: Expectations and concerns of patients with autoimmune and rheumatic diseases
por: Felten, Renaud, et al.
Publicado: (2021)

Évolution de l’immunité cellulaire et humorale anti-SARS-CoV-2 après 3 doses de vaccins chez des patients traités par rituximab
por: Felten, R., et al.
Publicado: (2021)

Different anti-SARS-CoV-2 vaccine response under B- and T-cell targeted therapies versus anti-cytokine therapies in patients with inflammatory arthritides
por: Felten, Renaud, et al.
Publicado: (2022)

Excess of Post-Acute Sequelae of COVID-19 After the First Wave of the Pandemic
por: Scherlinger, Marc, et al.
Publicado: (2022)

Difficulties and Psychological Impact of the SARS-CoV-2 Pandemic in Patients with Systemic Lupus Erythematosus: A Nationwide Patient Association Study
por: Scherlinger, Marc, et al.
Publicado: (2022)

Inclusion body myositis and Sjögren’s syndrome: the association works both ways
por: Giannini, Margherita, et al.
Publicado: (2022)

Chronic stimulation with SARS-CoV-2 spike protein does not trigger autoimmunity
por: Scherlinger, Marc, et al.
Publicado: (2023)

Dermatomyositis flare on imiquimod therapy highlights a crucial role of aberrant TLR7 signalling
por: Meyer, Alain, et al.
Publicado: (2016)

Refining “Long-COVID” by a Prospective Multimodal Evaluation of Patients with Long-Term Symptoms Attributed to SARS-CoV-2 Infection
por: Scherlinger, Marc, et al.
Publicado: (2021)

Long-term efficacy and safety of antitumour necrosis factor alpha treatment in rhupus: an open-label study of 15 patients
por: Danion, François, et al.
Publicado: (2017)

Tolerance and efficacy of targeted therapies prescribed for off-label indications in refractory systemic autoimmune diseases: data of the first 100 patients enrolled in the TATA registry (TArgeted Therapy in Autoimmune Diseases)
por: Gottenberg, Jacques-Eric, et al.
Publicado: (2022)

Théorie de la discontinuité : un rôle de l’infection à SARS-CoV-2 dans le développement de l’auto-immunité ?
por: Scherlinger, M., et al.
Publicado: (2022)

Experience and impact of the COVID-19 pandemic in patients with systemic lupus erythematosus in France
por: Scherlinger, M., et al.
Publicado: (2022)

Immunosuppressive agents for rheumatoid arthritis: a systematic review of clinical trials and their current development stage
por: Blaess, Julien, et al.
Publicado: (2020)

Difficultés et vécu de la pandémie Covid-19 des patients atteints de lupus systémique : résultats de l’enquête nationale EPICURE
por: Scherlinger, M., et al.
Publicado: (2021)

Cognitive Dysfunction and Dementia in Primary Sjögren's Syndrome
por: Blanc, Frederic, et al.
Publicado: (2013)

Innate immunity triggers IL-32 expression by fibroblast-like synoviocytes in rheumatoid arthritis
por: Alsaleh, Ghada, et al.
Publicado: (2010)

B lymphocytes and B-cell activating factor promote collagen and profibrotic markers expression by dermal fibroblasts in systemic sclerosis
por: François, Antoine, et al.
Publicado: (2013)

Primary Immunodeficiencies With Defects in Innate Immunity: Focus on Orofacial Manifestations
por: Jung, Sophie, et al.
Publicado: (2020)

How and why are rheumatologists relevant to COVID-19?
por: Felten, Renaud, et al.
Publicado: (2020)

Comment et pourquoi les rhumatologues sont importants face à la crise du COVID-19 ?()
por: Felten, Renaud, et al.
Publicado: (2020)

Systemic lupus erythematosus and neutropaenia: a hallmark of haematological manifestations
por: Meyer, Aurore, et al.
Publicado: (2020)

Coordination régionale et suivi prospectif du traitement prophylactique et curatif de 301 patients traités par anticorps monoclonaux anti-SARS-CoV-2
por: Licinio, P., et al.
Publicado: (2022)

No evidence for an association between the -871 T/C promoter polymorphism in the B-cell-activating factor gene and primary Sjögren's syndrome
por: Gottenberg, Jacques-Eric, et al.
Publicado: (2006)

Progressive multifocal leukoencephalopathy and sarcoidosis under interleukin 7: The price of healing
por: Guffroy, Aurélien, et al.
Publicado: (2020)

Granulomatous manifestations associated with COVID19 infection: Is there a link between these two diseases?
por: Mertz, Philippe, et al.
Publicado: (2021)

Shared development of targeted therapies among autoimmune and inflammatory diseases: a systematic repurposing analysis
por: Petitdemange, Arthur, et al.
Publicado: (2020)

Prescription strategy of antimalarials in cutaneous and systemic lupus erythematosus: an international survey
por: Petitdemange, Arthur, et al.
Publicado: (2021)

Infection risk among adults with down syndrome: a two group series of 101 patients in a tertiary center
por: Guffroy, Aurélien, et al.
Publicado: (2019)

Serological Evidence of Influenza D Virus Circulation Among Cattle and Small Ruminants in France
por: Oliva, Justine, et al.
Publicado: (2019)

Beyond Anti-viral Effects of Chloroquine/Hydroxychloroquine
por: Gies, Vincent, et al.
Publicado: (2020)

Psoriatic arthritis with hyperuricemia: more peripheral, destructive, and challenging to treat
por: Widawski, L., et al.
Publicado: (2022)

Immune Defect in Adults With Down Syndrome: Insights Into a Complex Issue
por: Dieudonné, Yannick, et al.
Publicado: (2020)

Ce que nous apprennent nos HDJ sur la réponse vaccinale anti-SARS-CoV-2 différente sous traitements ciblant les lymphocytes B et T par rapport aux traitements anti-cytokiniques
por: Felten, R., et al.
Publicado: (2021)

Follow-up of COVID-19 patients: LA is transient but other aPLs are persistent
por: Vollmer, Olivier, et al.
Publicado: (2021)

Identification of autoreactive B cells with labeled nucleosomes
por: Gies, Vincent, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_3deut2o4anf79pn1vftmm49nlf